Verve Therapeutics, Inc.
Verve Therapeutics, Inc. (VERV) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · VERV · as of Jun 9, 2026
Key Statistics
Explore Verve Therapeutics, Inc. Data
verv stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 13 · Buy rate: 30.8%
The VERV analyst consensus is Hold, based on ratings from 13 Wall Street analysts over the past 3 months. The average 12-month price target is $18.00, representing +61.73% upside from the current price of $11.13.
Competitors & Peers
verv competitorsVERV
ALBO
CBIO
CDMO
EQRX
ETHZStock Performance
Full HistoryAbout Verve Therapeutics, Inc.
Verve Therapeutics, Inc. is a biotechnology firm dedicated to pioneering gene-editing treatments for individuals afflicted with cardiovascular diseases. Their flagship experimental therapy, VERVE-101,…
what is verve therapeutics, inc. · verv stock overview · verve therapeutics, inc. company profile · who is verve therapeutics, inc. ceo · verv NASDAQ · verve therapeutics, inc. headquarters · verve therapeutics, inc. business segments
About Stock Overview & Key Data
Verve Therapeutics, Inc. (VERV) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 17, 2021. As of the latest trading session, VERV stock price is $11.13, with a market capitalization of $994.0M. The stock has returned +117.81% over the past 12 months and +85.19% year-to-date.
According to 13 Wall Street analysts, the consensus rating for Verve Therapeutics, Inc. stock is Hold, with an average 12-month price target of $18.00. In fiscal year 2024, Verve Therapeutics, Inc. reported revenue of $32.3M and net income of -$198.7M. For detailed data — including Verve Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Verve Therapeutics, Inc. (VERV) stock price is $11.13. The stock is traded on NASDAQ under the ticker symbol VERV. The 52-week range is $2.87 – $11.40.